GENEVA/LONDON - Final stage of testing of an experimental Ebola vaccine being developed by Merck and NewLink Genetics will begin in Guinea on March 7, the World Health Organization said on Thursday.
WASHINGTON - The U.S. Supreme Court appeared sharply divided on ideological lines on Wednesday as it tackled a second major challenge to President Barack Obama's healthcare law, with Justice Anthony Kennedy emerging as a likely swing vote in a ruling. | Video
BRUSSELS - U.S. medical device maker Boston Scientific Corp's German arm is liable for the cost of operations to replace potentially defective pacemakers, Europe's top court ruled on Thursday.
LOS ANGELES - A second top Los Angeles hospital has reported an outbreak of drug-resistant "superbug" infections, and dozens more potential exposures, from procedures performed with a fiber-optic instrument called a duodenoscope.
WASHINGTON - U.S. health regulators issued an updated safety alert on Wednesday for endoscopes linked to drug-resistant "superbug" bacteria in California hospitals.
FRANKFURT - German drugmaker Bayer said it would not get any relevant results from a Phase III trial of regorafenib, a drug also known as Stivarga, for the treatment of colorectal cancer, because it failed to recruit a sufficient number of participants.
NEW YORK - U.S. hospital executives said on Wednesday they were optimistic they will avoid the toughest consequences of a Supreme Court decision on whether millions of Americans can continue to purchase subsidized health benefits under Obamacare.
LOS ANGELES/CHICAGO - McDonald's Corp's U.S. restaurants will gradually stop buying chicken raised with antibiotics vital to fighting human infections, the most aggressive step by a major food company to change chicken producers' practices in the fight against dangerous 'superbugs.' | Video
NEW YORK - The director of the U.S. National Cancer Institute will step down later this month after nearly five years at the helm of the agency that supports basic research on cancer in academia, industry, and its own labs, the National Institutes of Health announced on Wednesday.
- Johnson & Johnson is close to buying cancer drug maker Pharmacyclics Inc in the coming days, the Financial Times reported, citing sources.